Large-scale testing (Phase 3)Study completedNCT00604630
What this trial is testing
Multicenter Efficacy Study of Recombinant Human Erythropoietin in Acute Ischemic Stroke
Who this might be right for
Infarction, Middle Cerebral ArteryMiddle Cerebral Artery StrokeStroke, Acute
Max-Planck-Institute of Experimental Medicine 522